Signopam

Q: Is this product safe to consume?

No. This product has been recalled due to: Reduced temazepam release may lead to insufficient patient exposure, lack of hypnotic and sedative efficacy, and risk of inappropriate treatment, including dose escalation and variability of effect. Potential effects: reduced treatment efficacy, need to change therapy.

Reduced temazepam release may lead to insufficient patient exposure, lack of hypnotic and sedative efficacy, and risk of inappropriate treatment, including dose escalation and variability of effect. Potential effects: reduced treatment efficacy, need to change therapy.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

Medium

Manufacturer

Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.

Batch Number

11122

Recall Date

06.10.2025

Frequently Asked Questions

Is this product safe to consume?

No. This product has been recalled due to: Reduced temazepam release may lead to insufficient patient exposure, lack of hypnotic and sedative efficacy, and risk of inappropriate treatment, including dose escalation and variability of effect. Potential effects: reduced treatment efficacy, need to change therapy.

What should I do if I already bought this?

Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.

Signopam

Frequently Asked Questions

Other Recalled Products

Krople uspokajające spokojne

Curosurf

Curosurf

Sunitinib MSN

Tullex